TY  - JOUR
AU  - Rubini-Costa, Ricardo
AU  - Bermúdez-Jiménez, Francisco
AU  - Rivera-López, Ricardo
AU  - Sola-García, Elena
AU  - Nagib-Raya, Hadi
AU  - Moreno-Escobar, Eduardo
AU  - López-Zúñiga, Miguel Ángel
AU  - Briones-Través, Adela
AU  - Sanz-Herrera, Francisco
AU  - Sequí-Sabater, Jose Miguel
AU  - Romero-Cabrera, Juan Luis
AU  - Maíllo-Seco, Javier
AU  - Fernández-Vázquez, Felipe
AU  - Rivadeneira-Ruiz, María
AU  - López-Valero, Lucas
AU  - Gómez-Navarro, Carlos
AU  - Aparicio-Gómez, Jose Antonio
AU  - López, Miguel Álvarez
AU  - Tercedor, Luis
AU  - Molina-Jiménez, María
AU  - Macías-Ruiz, Rosa
AU  - Jiménez-Jáimez, Juan
PY  - 2022
DO  - 10.1016/j.medcli.2021.06.015
UR  - http://hdl.handle.net/20.500.12105/15928
AB  - Atrial fibrillation (AF) is common in patients admitted with severe COVID-19. However, there is limited data about the management of chronic anticoagulation therapy in these patients. We assessed the anticoagulation and incidence of major...
LA  - eng
PB  - Elsevier
KW  - Atrial Fibrillation
KW  - COVID-19
KW  - Thrombosis
KW  - Anticoagulants
KW  - Hemorrhage
KW  - Humans
KW  - Prevalence
KW  - Retrospective Studies
KW  - Risk Factors
KW  - SARS-CoV-2
TI  - Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection.
TY  - journal article
ER  -